Evidence map›Paper›PMID 33620147›Full record

ArticleAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc2021

SD + SV4 diagnosis of left ventricular hypertrophy, a revaluation of ECG criterion by cardiac magnetic resonance imaging.

Demin Liu, Hanqi Su, Bailin Wu, Di Zhu, Guoqiang Gu, Dina Xie, Wei Cui

Open access · goldAbstract read
In one paragraph

Article in Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. SD + SV4 diagnosis of left ventricular hypertrophy, a revaluation of ECG criterion by cardiac magnetic resonance imaging.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Demin LiuDepartment of Cadiology, Second hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.
Hanqi SuDepartment of Cadiology, Second hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.
Bailin WuDepartment of Radiology, Second hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.
Di ZhuDepartment of Endocrine, Air Force General Hospital PLA, Beijing, China.
Guoqiang GuDepartment of Cadiology, Second hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.
Dina XieDepartment of Cardiac surgery, Tianjin Medical University General Hospital, Tianjin, China.
Wei CuiDepartment of Cadiology, Second hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.ORCID 0000-0002-1214-4146
Hebei Medical University · CNAir Force General Hospital PLA · CNTianjin Medical University General Hospital · CN

Funding

2017-CCA-xinxin merck fund-011China Cardiovascular Association-Cardiac rehabilitation and Metabolic therapy research fundHebei Natural Science Foundation H2020206409National Natural Science Foundation of China 81700281
6 · The paper itself

Abstract

backgroudPresent electrocardiogram (ECG) criteria for diagnosing left ventricular hypertrophy (LVH) usually have low sensitivity, while the newly proposed SD + SV4 criterion, namely the deepest S-wave amplitude in any lead (SD) plus SV4 amplitude, has been reported to have higher sensitivity and accuracy compared with other existing criteria. We aimed to further evaluate the diagnostic value of the SD + SV4 criterion in reference to the gold standard cardiac magnetic resonance imaging (CMR) in LVH diagnosis.

methodsThis retrospective study enrolled 138 patients who received CMR examination-60 patients with reduced ejection fraction (EF) and 78 patients with preserved EF. The left ventricular mass index (LVMI) measured by CMR was used as the gold standard for diagnosing LVH.

resultThe diagnostic value of the SD + SV4 criterion was compared with other 4 commonly used criteria. By CMR, 29 out of 138 people (21%) were diagnosed with LVH in reference to CMR. The SD + SV4 criterion had markedly higher sensitivity in diagnosing LVH compared with other criteria, but no higher specificity. There was no significant difference in area under receiver operating characteristic (ROC) curve among these criteria. The SD + SV4 criterion was not markedly consistent with CMR in diagnosing LVH. Compared to the other criteria, the SD + SV4 criterion had the highest sensitivity in patients with reduced ejection fraction; however, the area under the curve (AUC) of the SD + SV4 criterion in patients with reduced EF was significantly lower than in patients with preserved EF.

conclusionThe newly proposed SD + SV4 criterion did not have a better diagnostic value compared with other existing criteria, and the statistical power of the SD + SV4 criterion was influenced by EF.

Indexed as

ElectrocardiographyHypertrophy, Left VentricularHeartHumansMagnetic Resonance ImagingRetrospective StudiesSensitivity and SpecificityCMRelectrocardiographyleft ventricular hypertrophyleft ventricular mass indexSD + SV4 criterion

Identifiers

PMID33620147
PMCPMC8293603
OpenAlexW3131297749

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.